{"nct_id":"NCT00540943","title":"Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2007-07-13","start_date_type":"ACTUAL","primary_completion_date":"2010-05-03","primary_completion_date_type":"ACTUAL","completion_date":"2010-05-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}